Dermapharm Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Dermapharm Contact Number

DERMAPHARM Company Profile CASABLANCA, …

4 hours ago Dnb.com Show details

DERMAPHARM is located in CASABLANCA, Morocco and is part of the Miscellaneous Durable Goods Merchant Wholesalers Industry. DERMAPHARM has 10 total employees across all of its locations and generates $294,140 in sales (USD). (Employees figure is modelled).

Employees: 10
Location: 50 RUE 24, CASABLANCA, 20450

Category: Contact NumberShow more

DermaPharm A/S Overview, News & Competitors …

1 hours ago Zoominfo.com Show details

45 86 47DermaPharm A/S’s headquarters are in Europavej 10, Farup, North Denmark, 8990, Denmark What is DermaPharm A/S’s phone number? DermaPharm A/S’s phone number is +45 86 47 77 44

Employees: 87
Phone: 86 47 77 44
Location: Europavej 10, Farup, 8990, North Denmark

Category: Contact NumberShow more

Dermapharm AG Company Profile Hünenberg, ZUG

7 hours ago Dnb.com Show details

Company Description: Dermapharm AG is located in Hünenberg, ZUG, Switzerland and is part of the Drugs and Druggists' Sundries Merchant Wholesalers Industry. Dermapharm AG has 5 employees at this location and generates $1.32 million in sales (USD). (Employees and Sales figures are modelled).

Employees: 5
Phone: 417856340
Location: Bösch 104, Hünenberg, 6331, ZG

Category: Contact NumberShow more

DermaPharm, KwaZulu Natal (+27860432584)

9 hours ago Vymaps.com Show details

860 432 584List of Drug Approvals by the Medicines Control Council in South Africa containing Biotin Dermapharm Brand on PharmaCompass.com. DERMAPHARM - K2020232972 - South Africa - B2BHint b2bhint.com DERMAPHARM South African company. Was founded on May 22, 2020 with identification number K2020232972 based on 6 SWAPO ROAD, DURBAN NORTH, …

Location: 6 Swapo Rd, 4051 Durban, KwaZulu-Natal
Phone: 0860 432 584

Category: Contact NumberShow more

Dermapharm Crunchbase Investor Profile & Investments

Just Now Crunchbase.com Show details

Industries. Pharmaceutical. Headquarters Regions European Union (EU) Founded Date 1991. Operating Status Active. Company Type For Profit. Phone Number +49 (0) 89 6 41 86-0. Dermapharm is a drug specialists in the field of dermatology with their own production, development and independent distribution.

Founded: 1991

Category: Contact NumberShow more

Dermapharm Company Profile Office Locations, Competitors

7 hours ago Craft.co Show details

Dermapharm. Frequently Asked Questions. When was Dermapharm founded?. Dermapharm was founded in 1991.. How many employees does Dermapharm have?. Dermapharm has 2,311 employees.. Who are Dermapharm competitors?. Competitors of Dermapharm include Galderma, Recordati and Medicata Filia.. Where is Dermapharm

Category: Contact NumberShow more

Products Dermapharm

7 hours ago Dermapharm.de Show details

41 86-130Dermapharm AG Lil-Dagover-Ring 7 82031 Grünwald Germany Phone: +49 (89) 6 41 86-0 Fax: +49 (89) 6 41 86-130 E-Mail: service[at]dermapharm[dot]de

Category: Contact NumberShow more

Dermapharm Holding SE Investor Relations

7 hours ago Ir.dermapharm.de Show details

Dermapharm has been listed on the regulated market (Prime Standard) of the Frankfurt Stock Exchange since February 9, 2018. At 65.05%, the majority of no-par value shares are owned by Themis Beteiligungs-Aktiengesellschaft. 34.95% of the shares of Dermapharm Holding SE are in free float as defined by Deutsche Börse.

Category: Contact NumberShow more

DERMAPHARM LIMITED Overview (free company information

5 hours ago Find-and-update.company-information.service.gov.uk Show details

DERMAPHARM LIMITED. Company number 03480801. Follow Filing history for DERMAPHARM LIMITED (03480801) People for DERMAPHARM LIMITED (03480801) More for DERMAPHARM LIMITED (03480801) Registered office address Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB Contact us; Accessibility statement

Category: Contact NumberShow more

Customer Service Customer Service

3 hours ago Dermarpx.com Show details

844-475-3606Please allow 24-48 hours from placing your order until it's updated in our systems. For customer service, please call 1-844-475-3606 between the hours of 8:00AM - 8:00PM EST. We are committed to providing the best products and friendliest customer service. If you should have any questions about ordering or a question a

Category: Customer ServiceShow more

DermaPharm A/S

7 hours ago Derma.dk Show details

89 45 31Derma er produceret af DermaPharm A/S · Europavej 10 · DK-8990 Fårup CVR: 89 45 31 19 · Tlf.: + 45 86 47 77 44 · E-mail: [email protected] · www.dermapharm.dk Cookies og persondatapolitik

Category: Contact NumberShow more

Canopy Growth Divests Pharmaceutical C3 Cannabinoid

2 hours ago Canopygrowth.com Show details

As part of the agreement, all C³ employees will be retained by Dermapharm following the closing of the transaction. 1 Based on the Bank of Canada’s daily exchange rate on December 14, 2021 Media Contact: Niklaus Schwenker Director, Communications [email protected] Investor Contacts: Tyler Burns Director, Investor …

Category: Contact NumberShow more

Pot producer Canopy to sell German pharma unit C3 on COVID

2 hours ago Ca.news.yahoo.com Show details

Shares of Canopy were down 3.4% at C$8.85 in afternoon trading. The Ontario-based company said it would get an upfront payment of about C$115.5 million ($89.51 million) from German pharmaceutical firm Dermapharm Holding SE once the deal closes in January, and up to C$61.4 million in a milestone-based payment. That is lower than the C$342.9 million …

Category: Contact NumberShow more

Canopy Growth Corporation (CGC) Divests Pharmaceutical C3

7 hours ago Marijuanastocks.com Show details

About Dermapharm Dermapharm is a rapidly growing manufacturer of branded pharmaceuticals. Founded in 1991, the Company is based in Grünwald near Munich. The Company’s integrated business model comprises in-house development, production and the distribution of brand products by a trained pharmaceutical sales force.

Category: Contact NumberShow more

Contact Us DermapenWorld

Just Now Dermapenworld.com Show details

Professional Enquiry. First name*. 0 of 40 max characters. Last name*. Email*. Phone *. Company Name. Subject *. choose an option below Microneedling at Home LED Light Therapy Dp Dermaceuticals Skincare Dermapen Treatments in Clinic Expert Advice Shipping, Returns & Exchanges Something else.

Category: Contact SupportShow more

Dermapharm Holding SE: Acquisition of C³ Cannabinoid

4 hours ago Uk.finance.yahoo.com Show details

Contact. Investor Relations & Corporate Communications Britta Hamberger Tel.: +49 (0)89 - 64186-233 Fax: +49 (0)89 - 64186-165 E-Mail: [email protected]dermapharm.com. 15-Dec-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Category: Contact NumberShow more

List of nationally authorised medicinal products

5 hours ago Ema.europa.eu Show details

232.00.00Authorisation number National Authorisation Number MAH of product in the member state Member State where product is authorised Fusicutan plus Betamethason 20 mg/g + 1 mg/g Creme AT/H/0600/001 94232.00.00 DERMAPHARM AG DE Fucicort® Lipid 20 mg/g + 1 mg/g Creme not available 61359.00.00 LEO PHARMA GMBH DE Fucicort® 20 mg/g + 1mg/g Creme

Category: Contact NumberShow more

Dermapharm Holding SE: Acquisition of C³ Cannabinoid

1 hours ago Marketscreener.com Show details

Dermapharm Holding SE: Acquisition of C³ Cannabinoid Compound Company GmbH. Grünwald, December 15, 2021 - Dermapharm Holding SE (WKN: A2GS5D, ISIN: DE000A2GS5D8), through Dermapharm AG, today entered into an agreement with Canopy Growth Germany GmbH, based in St. Leon-Rot, Germany, to acquire C³ Cannabinoid …

Category: Contact NumberShow more

Canopy Growth selling C3 Cannabinoid Compound Company …

6 hours ago Kelownadailycourier.ca Show details

SMITHS FALLS, ONT. - Canopy Growth Corp. says it has signed a deal to sell its C3 Cannabinoid Compound Company GmbH subsidiary to German company Dermapharm Holding SE. Under the agreement, Canopy will receive an upfront payment of $115.5 million. It will also receive up an additional $61.4 million

Category: Contact NumberShow more

Canopy Growth Divests Pharmaceutical C3 Cannabinoid

5 hours ago Finance.yahoo.com Show details

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH ("C3

Category: Contact NumberShow more

Canopy Growth sells cannabinoid company to Germany's

5 hours ago Cannabiswealth.co.uk Show details

Canopy Growth has entered into the agreement with German-based pharmaceutical company Dermapharm Holding SE. The company will be selling its subsidiary cannabinoid business, C³ Cannabinoid Compound Company GmbH (C3), to European pharmaceutical company, Dermapharm, in Grünwald, Germany.. Canopy Growth has said the …

Category: Contact NumberShow more

Canopy Growth Divests Pharmaceutical C3 Cannabinoid

3 hours ago Theartofmaryjanemedia.com Show details

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in …

Category: Contact NumberShow more

Canopy Growth Corporation (CGC) Divests Pharmaceutical C3

4 hours ago Streetinsider.com Show details

Dermapharm is a rapidly growing manufacturer of branded pharmaceuticals. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered

Category: Contact NumberShow more

Canopy Growth Divests Pharmaceutical C3 Cannabinoid

1 hours ago Technical420.com Show details

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in …

Category: Contact NumberShow more

Canopy Growth to sell German medical marijuana business C3

8 hours ago Leaderpost.com Show details

Canopy, which bought C3 in 2019 in an all-cash $342.9 million deal, is selling the unit to Germany's Dermapharm. Staff work in a marijuana grow room at Canopy Growth's Tweed facility in Smiths

Category: Contact NumberShow more

Canopy Growth Divests Pharmaceutical C3 Cannabinoid

2 hours ago Stockhouse.com Show details

About Dermapharm Dermapharm is a rapidly growing manufacturer of branded pharmaceuticals. Founded in 1991, the Company is based in Grünwald near Munich. The Company's integrated business model comprises in-house development, production and the distribution of brand products by a trained pharmaceutical sales force.

Category: Contact NumberShow more

UAE eases drug laws for travellers, raising questions on

6 hours ago Cannabiswealth.co.uk Show details

A number of foreigners have been imprisoned by the UAE for what the country constitutes as crimes, including having prescription medicines. The recent case of 24-year-old Billy Hood saw the British footballer sentenced to 25 years in prison in Dubai following the discovery of four bottles of CBD in his car.

Category: Contact NumberShow more

Bite Away Trademark Dermapharm Ag Bizapedia

Just Now Bizapedia.com Show details

Mark Identification: BITE AWAY: Last Applicant/Owner: Dermapharm Ag Lil-Dagover-Ring 7 82031 Grünwald: Serial Number: 79242952: Filing Date: July 11, 2018

Category: Contact NumberShow more

DGAPNews: Dermapharm Holding SE raises EBITDA forecast

6 hours ago Markets.businessinsider.com Show details

Dermapharm Holding SE raises EBITDA forecast for the full year 2021 Grünwald, December 16, 2021 - Dermapharm Holding SE ("Dermapharm"), a high-growth manufacturer of branded pharmaceuticals, is

Category: Contact NumberShow more

DGAPAdhoc: Dermapharm Holding SE raises EBITDA forecast

7 hours ago Markets.businessinsider.com Show details

Dermapharm Holding SE raises EBITDA forecast for the full year 2021 16-Dec-2021 / 12:08 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014

Category: Contact NumberShow more

CONTACT US – Dermpath Diagnostics

3 hours ago Dermpathdiagnostics.com Show details

866.625.3309CONTACT US. Your comments and inquires are important to us. Enter your comments below and tell us how we may reach you. Thank you for visiting DermpathDiagnostics.com. For the following departments, please reach out directly Billing and invoice questions, please call 1.866.625.3309

Category: Contact SupportShow more

Backahill enters into an agreement to sell AB Cernelle

6 hours ago Cernelle.com Show details

About Dermapharm AG: German Dermapharm AG is a listed pharmaceutical group active in specialty drugs, generic and over-the-counter products. The turnover in 2020 was 794 million euros and it has about 2,300 employees in Germany and internationally.

Category: Contact NumberShow more

Canopy Growth Corporation (CGC) Divests Pharmaceutical C3

7 hours ago Marketwatch.com Show details

021-12-15Dec 15, 2021 (Marijuana Stocks via COMTEX) -- Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company …

Category: Contact NumberShow more

Pot producer Canopy to sell German pharma unit C3 on COVID

4 hours ago Marketscreener.com Show details

The Ontario-based company said it would get an upfront payment of about C$115.5 million ($89.51 million) from German pharmaceutical firm Dermapharm Holding SE once the deal closes in January, and up to C$61.4 million in a milestone-based payment. That is lower than the C$342.9 million Canopy paid in 2019 to buy C3, which it had often described

Category: Contact NumberShow more

epiivo, An Australia Trademark of Dermapharm

2 hours ago Trademarkelite.com Show details

The epiivo trademark was assigned an Application Number # 2088285 by the Australia Intellectual Property Office (IP Australia). Trademark Application Number is a Unique ID to identify the epiivo mark in IP Australia.. The epiivo mark is filed in the category of Class 010 Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and …

Category: Contact NumberShow more

Effect of topical treatment with 7.5% urea in Ichthyosis

1 hours ago Onlinelibrary.wiley.com Show details

The mechanism of action of urea in skin treatment is not completely understood, but studies suggest the treatment acts both keratolytic and moisturising and may even alter gene expression of proteases in the epidermis. 4-6 From 1968 to 2020 only five studies have evaluated the effect of (10%) urea cream by comparing with a control treatment and

Category: Contact NumberShow more

German Pharmaceutical Firm Enters Cannabis Space With

Just Now Businesscann.com Show details

FURTHER evidence of pharmaceutical interest in the European cannabis space has emerged with German business Dermapharm Holding acquiring Canopy Growth subsidiary C³ Group. C³ specialises in the development, production and marketing of natural and synthetic cannabinoids and was purchased by Canopy in 2019 for €235m. Canopy has now sold the …

Category: Contact NumberShow more

South Africa: Prof Benny Clinches Brazilian Export Order

1 hours ago Theartofmaryjanemedia.com Show details

Professor Benny de Beer’s CBD Full Spectrum has clinched South Africa’s first cannabis export order to Brazil. And the company has received SAHPRA approval to launch three cannabis products locally, to treat anxiety. The SAHPRA-licensed Vanderbiljpark grow-op is rapidly expanding its capacity from four greenhouses with an additional 10 tunnels being …

Category: Contact NumberShow more

Canopy Growth Takes Major Loss Divesting C3 Cannabinoid

6 hours ago Thedeepdive.ca Show details

The company, naturally, took a major loss on the investment. Originally acquired in May 2019 via an all-cash acquisition, the company paid a total of C$342.9 million for the company which was at the time claimed to be a “transformative deal.”. Two years later, the firm is disposing of the asset for C$115.5 million.

Category: Contact NumberShow more

The Daily Chase: Budgeting for Omicron; Inflation stays

7 hours ago Bnnbloomberg.ca Show details

The headline number masks especially hot markets like Toronto (where the aggregate price is expected to rise 11 per cent to $1.26 million). The Bank of Canada has a new second-in-command as of today. This is scheduled to be Carolyn Rogers’ first day as the central bank’s senior deputy governor.

Category: Contact NumberShow more

Most actively traded companies on the Toronto Stock

6 hours ago Kelownadailycourier.ca Show details

Canopy Growth Corp. (TSX:WEED). Up 17 cents or 1.4 per cent to $11.92. Canopy Growth Corp. says it has signed a deal to sell its C3 Cannabinoid Compound Company GmbH subsidiary to German company Dermapharm Holding SE. Under the agreement, Canopy will receive an upfront payment of $115.5 million.

Category: Contact NumberShow more

High inflation is latest threat to cannabis businesses

8 hours ago Mjbizdaily.com Show details

December 17, 2021 - Updated December 17, 2021. The business story of the holiday season – record-breaking inflation caused by supply-chain pressure – has hit the cannabis industry especially hard. That’s because competition across the THC spectrum is forcing cannabis entrepreneurs to drop prices on everything from vapes and flower to

Category: Contact NumberShow more

Goodness Growth Holdings to Report Third Quarter Results

7 hours ago Investingnews.com Show details

Goodness Growth Holdings, Inc. a physician-led, science-focused cannabis company and IP incubator, today announced that it will report financial results for its third quarter ended September 30

Category: Contact NumberShow more

Canopy Growth Divests Pharmaceutical C3 Cannabinoid

9 hours ago Investingnews.com Show details

(212) 355-4648Contact Information: Bragar Eagel & Squire, P.C. Brandon Walker, Esq. Alexandra B. Raymond, Esq. (212) 355-4648 [email protected] www.bespc.com News Provided by GlobeNewswire via QuoteMedia

Category: Contact NumberShow more

Ederma Pharma Franchise in India Derma Franchise

8 hours ago Edermapharma.com Show details

We care about our Associates and we know about there all requirements. So when you join our e-derma pharma family you don't have to fear about advertising and marketing. e-derma pharma wil provide you all marketing and promotional support which will help you to grow and expand your business. e-derma pharma will provide you a great package of promotional tools which …

Category: Contact NumberShow more

Enbridge Inc (ENBT) Quote Press Release The Globe and

5 hours ago Theglobeandmail.com Show details

Dermapharm is a European pharmaceutical company based in Gruenwald, Germany. Contact Us. Address and Phone Number. Public Editor. Staff. Staff PGP Directory.

Category: Contact NumberShow more

Börse Express – Dr. Reuter IR on Biofrontera AG: Biotech

3 hours ago News.in-24.com Show details

Total v fulfilled Dermapharm has around 1,300 drug approvals for around 400 active pharmaceutical ingredients. Dermapharm AG has been able to continuously increase its sales over the past few years. 2020 the company generated sales of € 793.8 million. The share price rose accordingly: The share price has roughly tripled in the past 3 years.

Category: Tech SupportShow more

Public Safety and Security Market worth $516.5 billion by

3 hours ago Sports.yahoo.com Show details

Contact: Mr . Aashish Mehra Canopy Growth is selling Germany-based C3 Cannabinoid Compound Company to the German pharmaceutical company Dermapharm Holding. A number of Bitcoin stocks

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What is Dermapharm?

Dermapharm is a rapidly growing manufacturer of branded pharmaceuticals. Founded in 1991, the Company is based in Grünwald near Munich. The Company's integrated business model comprises in-house development, production and the distribution of brand products by a trained pharmaceutical sales force.

What is the price of the Dermapharm deal in Canada?

The Ontario-based company said it would get an upfront payment of about C$115.5 million ($89.51 million) from German pharmaceutical firm Dermapharm Holding SE once the deal closes in January, and up to C$61.4 million in a milestone-based payment.

Who is the CEO of Dermapharm?

After founding Dermapharm in 1991, Mr. Beier served as Chief Executive Officer of Dermapharm AG. In 2017, he was appointed chairman of the supervisory board of Dermapharm. Mr. Beier and his family hold the majority of the company's shares via Themis Beteiligungs AG.

How many marketing authorisations does Dermapharm have?

In the "Branded pharmaceuticals and other healthcare products" segment, Dermapharm has approximately 1,300 marketing authorisations with more than 380 active pharmaceutical ingredients.

Popular Brands

Daikin
Denso
Demant
Dsv
Dlf
Dbs
Dsm
Dana